Sadagopan Nalini | Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development
スポンサーリンク
概要
- SADAGOPAN Naliniの詳細を見る
- 同名の論文著者
- Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Developmentの論文著者
関連著者
-
Sadagopan Nalini
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development
-
Sadagopan Nalini
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
Szekely-klepser Gabriella
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development
-
Zhang Yanhua
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development Gr
-
Cohen Lucinda
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
DUFIELD Dawn
Molecular Biology, Pfizer Global Research & Development
-
KLOVER Jon
Molecular Biology, Pfizer Global Research & Development
-
LI Wenlin
Department of Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research & Development
-
LEPSY Christopher
Department of Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research & Development, Groton
-
SMITH Danielle
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global R&D
-
ZIENTEK Michael
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global R&D
-
REDDY Anita
Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global R&D
-
Reddy Anita
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
Zientek Michael
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
Smith Danielle
Department Of Pharmacokinetics Dynamics And Metabolism Pfizer Global R&d
-
Lepsy Christopher
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development Gr
-
Dufield Dawn
Molecular Biology Pfizer Global Research & Development
-
Klover Jon
Molecular Biology Pfizer Global Research & Development
-
Li Wenlin
Department Of Pharmacokinetics Dynamics & Metabolism Pfizer Global Research & Development
著作論文
- Development and validation of an LC-MS/MS method for quantification of cyclic guanosine 3',5'-monophosphate (cGMP) in clinical applications : A comparison with a EIA method
- Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery